menu
    • menu

    Company profile for Sapience Therapeutics

    NEW Drugs in Dev: 2
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sapience Therapeutics is focused on discovering and developing peptide-based therapeutics to previously ‘undruggable’ targets for major unmet medical needs, particularly high mortality cancers. Our drug candidates target protein-protein interactions (“PPIs”) that are responsible for either making the cells cancerous or dampening the immune response against tumors. These targets are considered ‘undruggable’ becaus...
    Sapience Therapeutics is focused on discovering and developing peptide-based therapeutics to previously ‘undruggable’ targets for major unmet medical needs, particularly high mortality cancers. Our drug candidates target protein-protein interactions (“PPIs”) that are responsible for either making the cells cancerous or dampening the immune response against tumors. These targets are considered ‘undruggable’ because they are PPIs that reside inside of the cell, making them difficult to treat with small molecule drugs such as chemotherapies (which are incapable of disrupting PPIs) or newer biologic-based drugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sapience TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    500 Mamaroneck Ave Suite 320 Harrison, NY 10528
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sapiencetherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sapience Reports Positive Lucicebtide Phase 2 Data in GBM at ASCO
    Sapience Reports Positive Lucicebtide Phase 2 Data in GBM at ASCO

    22 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sapience-therapeutics-provides-positive-data-update-from-phase-2-trial-of-lucicebtide-plus-soc-in-patients-with-glioblastoma-at-the-2026-american-society-of-clinical-oncology-asco-annual-meeting-302779105.html

    PR NEWSWIRE
    22 May 2026
    Share Share
    Sapience Therapeutics Presents Phase 2 ST-316 Data at AACR 2026
    Sapience Therapeutics Presents Phase 2 ST-316 Data at AACR 2026

    20 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sapience-therapeutics-presents-first-clinical-results-from-phase-2-study-of-st316-first-in-class--catenin-antagonist-in-second-line-colorectal-cancer-at-the-american-association-for-cancer-research-aacr-annual-meeting-2026-302746755.html

    PR NEWSWIRE
    20 Apr 2026
    Share Share
    Sapience Therapeutics Attends 25th Needham Healthcare Conference
    Sapience Therapeutics Attends 25th Needham Healthcare Conference

    13 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sapience-therapeutics-announces-participation-in-the-25th-annual-needham-virtual-healthcare-conference-302739594.html

    PR NEWSWIRE
    13 Apr 2026
    Share Share
    Sapience Therapeutics to Present Posters at AACR Meeting 2025
    Sapience Therapeutics to Present Posters at AACR Meeting 2025

    26 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sapience-therapeutics-to-present-multiple-posters-at-the-american-association-for-cancer-research-aacr-annual-meeting-2025-302411365.html

    PR NEWSWIRE
    26 Mar 2025
    Share Share
    Sapience Presents ST316 Ph 1 Dose Data at ASCO GI Cancers Symposium
    Sapience Presents ST316 Ph 1 Dose Data at ASCO GI Cancers Symposium

    27 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sapience-therapeutics-presents-st316-phase-1-dose-escalation-data-at-the-2025-american-society-of-clinical-oncology-asco-gastrointestinal-gi-cancers-symposium-302360732.html

    PR NEWSWIRE
    27 Jan 2025
    Share Share
    Sapience Receives Orphan Drug Designation for ST316 in FAP
    Sapience Receives Orphan Drug Designation for ST316 in FAP

    19 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sapience-therapeutics-receives-fda-orphan-drug-designation-for-st316-a-first-in-class--catenin-antagonist-for-the-treatment-of-familial-adenomatous-polyposis-fap-302335639.html

    PR NEWSWIRE
    19 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search